Lilly Endowment Sells $259M of Eli Lilly (LLY) Stock
ELI LILLY & Co
Subscribe to track LLY
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Lilly Endowment Sells $259M of Eli Lilly (LLY) Stock
Company: ELI LILLY & Co (LLY) Form: 4 | Filed: 2025-11-03 Significance: Low
Insider: LILLY ENDOWMENT INC Title: null | Relationship: Ten Percent Owner
Transaction: • Type: Sell • Shares: 291,342 • Avg Price: $889.61 • Value: $259,179,145 • Owned After: 94,231,978
Key Insight: Despite the large dollar value, this sale represents a very small fraction (0.03%) of the company's market cap and a minor reduction (0.31%) in the Endowment's substantial holdings.
Market Context: This appears to be a routine portfolio management transaction by the foundation, not a significant signal on the company's outlook.
Comprehensive Analysis
SEC Filing Analysis: ELI LILLY & Co (LLY)
Executive Summary
- Trading Significance: Low
- Key Takeaway: Lilly Endowment Inc., a foundational 10%+ owner, executed a large-value sale of $259 million, which is immaterial relative to Eli Lilly's mega-cap status and the Endowment's total holdings.
- Market Impact: The transaction is unlikely to have a significant market impact due to its small size relative to the company's market capitalization and public float.
Company Information
| Field | Value |
|---|---|
| Company | ELI LILLY & Co |
| Ticker Symbol | LLY |
| CIK | 0000059478 |
| Industry | Pharmaceutical Preparations |
Insider Information
| Field | Value |
|---|---|
| Name | LILLY ENDOWMENT INC |
| CIK | 0000316011 |
| Title/Position | null |
| Relationship | Ten Percent Owner |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-10-31 |
| Transaction Code | S (Sale) |
| Security Type | Common Stock |
| Shares Involved | 291,342 (aggregated from 8 transactions) |
| Price Per Share | $889.61 (Weighted Average) |
| Total Value | $259,179,145 |
| Shares Owned After | 94,231,978 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $259,179,145 |
| % of Market Cap | 0.034% |
| Shares Transacted | 291,342 |
| % of Shares Outstanding | 0.031% |
| Post-Transaction Ownership | 94,231,978 shares (9.96% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: For a mega-cap company with a market capitalization of $772.28 billion, a $259 million transaction is considered routine and not financially material.
- Ownership Concentration: The sale was a minor reduction of the Endowment's position, trimming only 0.31% of its prior holdings. The Endowment remains a significant shareholder with approximately 9.96% of shares outstanding post-transaction.
- Transaction Significance: The sale falls well below the thresholds for moderate or high significance. Such sales by large foundations are often conducted for liquidity, diversification, or to fund philanthropic obligations, rather than as a commentary on the underlying company's performance.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The sale is too small relative to the company's size and the insider's total holdings to signal a change in sentiment. It is likely to be absorbed by the market with minimal price impact.
Volume & Sentiment
- Expected Volume Impact: Minimal. The transaction size is a fraction of the stock's typical daily trading volume.
- Sentiment Indicator: Neutral. The market generally understands that large foundations like Lilly Endowment periodically sell shares for operational purposes.
Additional Context
Transaction Notes
- Special Circumstances: The sale was executed across eight separate transactions on the same day at weighted average prices, as detailed in the filing's footnotes. This is a common practice for large block sales to minimize market impact.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
